Our Mission

Amprion revolutionizes diagnosis for brain diseases. Through molecular testing, we accelerate medical science for personalized medicine. 

Our Story

As a pioneer in Prion Detection Science™️, we believe precision medicine is the new frontier. Through our work, we strive to positively impact brain disease diagnosis and treatment as the world population ages rapidly. See our evolving scientific journey below.

Timeline 2007
2007
vid origin story 1

Once Upon A Time

Neuroscientist Claudio Soto teams up with molecular pathologist Dr. Russ Lebovitz to detect prions, aka misfolded proteins, to eliminate mad cow disease.
Watch Our Origin Story
Timeline 2010
2010
Amprion hero images 33.png

The Pivot

As mad cow disease dissipates, the team pivots, asking: Is there a parallel between misfolded proteins in mad cow disease and human brain disorders?

Watch Video To Learn More
Timeline 2013
2013
Amprion hero images 18.png 1

Aha Moment!

Dr. Soto proves there is a similarity and develops an assay to detect misfolded Abeta, a biomarker found in most Alzheimer’s patients.

Learn About Our Science
Amprion Icon 2014
2014
Amprion hero images 6.png

Amprion Was Born

The team expands research to detect other misfolded proteins, including Synuclein and Tau. 

Watch The Amprion Story
Timeline 2015
2015
Amprion hero images 95.png

Our Mission

Revolutionize molecular testing to help doctors diagnose brain diseases accurately. 

How Amprion Helps Doctors
Timeline 2017
2017
Amprions Science Accelerates Drug Development for Alzhiemers Disease.png

Our Science

Amprion expands its lab, conducting further scientific research using its proprietary Prion Detection Science™️.

How We Help Accelerate Drug R&D
Timeline 2018
2018
Biochemical Test Shows Promise for Diagnosing Parkinsons Disease

Scientists At Work

The company establishes a state-of-the-art clinical lab run by dedicated scientists and experts, not to mention tireless bots when humans are off the clock.

Learn How Our Science Works
Timeline 2019
2019
Science Lab

FDA Breakthrough Designation

The US FDA awards Amprion Breakthrough Device Designation for detecting misfolded Synuclein, a key brain disease biomarker.

Watch FDA Breakthrough Designation
Timeline Feb 2020
Feb 2020
Early Detection of Alzheimers Disease by Analyzing Spinal Fluid

Breakthrough Publishing

Dr. Soto published a research article in Nature. 

Learn More
Timeline 2020
2020
Amprion hero images 78.png

Covid Push For CLIA

Team Amprion, standing 6-feet apart, worked through Covid and reached a significant milestone. We achieved CLIA approval for our clinical lab.

View CLIA Certificate
Timeline 2021
2021
Amprion hero images 7.png

SYNTap Test Commercial Rollout

Our first biomarker test is here! This breakthrough test helps doctors diagnose Parkinson’s, Lewy Body Dementia by detecting misfolded Synuclein in CSF. 

Discover Here
amprion logo quote solid blue
Do good by doing well, do well by doing good.
Scroll to Top